ReNeuron to Present Positive Pre-Clinical Data Concerning its ReN005 Stem Cell Line for Huntington's Disease

Guildford, UK, 18 Oct 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will be participating in the 3rd World Congress on Regenerative Medicine, taking place at The Congress Center, Leipzig, Germany on 18-20 October. The Company will present in the Neurodegeneration and Repair stream on the morning of 20 October.

Back to news